← Open Payments lookup

ANNA VOLYNKINA: Open Payments

NPI 1003650185 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$541 in 17 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $541

Food & beverage: $541
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.1$144
Kowa Pharmaceuticals America, Inc.4$128
ABBVIE INC.3$85
Otsuka America Pharmaceutical, Inc.3$55
Astellas Pharma US Inc1$31
Sumitomo Pharma America, Inc.1$27
Boehringer Ingelheim Pharmaceuticals, Inc.1$20
PFIZER INC.1$18
Aimmune Therapeutics, Inc.1$17
Novo Nordisk Inc1$16

Products named: Kerendia, ZORYVE, LINZESS, REXULTI, Veozah, QULIPTA, GEMTESA, JARDIANCE.

Industry payments across WA — which companies pay providers there.